Oska Wellness

Executive Summary

Oska Wellness, founded in 2014 and headquartered in Carlsbad, California, develops the Oska Pulse, a non-invasive, drug-free Pulsed Electromagnetic Field (PEMF) device designed to relieve chronic pain by targeting inflammation, improving circulation, and enhancing mobility. The company operates at the intersection of digital health and medical devices, addressing the growing demand for alternative pain management solutions amid the opioid crisis. Oska Pulse is marketed directly to consumers and through healthcare professionals, competing with other PEMF devices like BEMER and iMRS, but differentiating on portability and ease of use. With an aging population and increasing prevalence of chronic conditions such as arthritis and back pain, Oska Wellness is positioned to capture a share of the $70+ billion global pain management market. The company has secured regulatory clearances in the US (FDA) and international markets, and continues to invest in clinical evidence to support efficacy claims. Despite being a private company with limited public financials, its direct-to-consumer model and relatively low price point make it accessible. Future growth will likely hinge on expanding insurance coverage, securing larger retail partnerships, and obtaining FDA clearances for additional indications.

Upcoming Catalysts (preview)

• Q2 2026FDA clearance for new pain indication (e.g., osteoarthritis of the knee)65% success
• Q3 2026Positive results from a randomized controlled trial on chronic low back pain published in a peer-reviewed journal70% success
• Q4 2026Strategic partnership with a national pharmacy chain or large healthcare provider for distribution50% success